Literature DB >> 9082264

Outcome of orbital myositis. Clinical features associated with recurrence.

G E Mannor1, G E Rose, I F Moseley, J E Wright.   

Abstract

PURPOSE: Although orbital myositis usually responds to prompt systemic therapy, recurrent or persistent episodes often require prolonged therapy. This study presents the clinical and radiologic features of 26 patients with orbital myositis and suggests a treatment regimen with special emphasis on recurrent or persistent orbital myositis.
METHODS: Retrospective analysis and comparison of clinical and radiologic parameters with clinical outcome in 26 patients with strictly defined orbital myositis was performed. A consultant radiologist reviewed computed tomography studies without knowledge of the clinical data or outcome. The frequency of certain clinical and radiologic parameters among two outcome groups was analyzed using Fisher's exact test.
RESULTS: Comparison of clinical and radiologic features of 20 patients with a single acute episode and 6 patients with recurrent episodes disclosed several characteristics associated with recurrence. Male gender, lack of proptosis, eyelid retraction, horizontal extraocular muscle (EOM) involvement, multiple or bilateral EOM involvement (P = 0.05), muscle tendon sparing, and lack of response to systemic corticosteroids (P = 0.01), or nonsteroidal anti-inflammatory agents (P = 0.01) were associated with recurrent orbital myositis.
CONCLUSIONS: A treatment algorithm is suggested for patients with orbital myositis. Those patients whose clinical or radiologic features are associated with recurrence may benefit from early systemic steroid therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9082264     DOI: 10.1016/s0161-6420(97)30300-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Factors associated with multiple recurrences of nonspecific orbital inflammation aka orbital pseudotumor.

Authors:  Puneet S Braich; Robin K Kuriakose; Naveen S Khokhar; Jared C Donaldson; Timothy J McCulley
Journal:  Int Ophthalmol       Date:  2017-06-20       Impact factor: 2.031

2.  Orbital myositis in scleritis.

Authors:  Z F H M Boonman; R J W De Keizer; H S Graniewski-Wijnands; P G Watson
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

Review 3.  "Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

Authors:  F Montagnese; S Wenninger; B Schoser
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

4.  Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients.

Authors:  S Y Jang; S Y Lee; E J Lee; J S Yoon
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

5.  [Ocular myositis as a rare cause of vision loss].

Authors:  J D Rollnik; H Requadt
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

6.  Consensus on Diagnostic Criteria of Idiopathic Orbital Inflammation Using a Modified Delphi Approach.

Authors:  Ilse Mombaerts; Jurij R Bilyk; Geoffrey E Rose; Alan A McNab; Aaron Fay; Peter J Dolman; Richard C Allen; Martin H Devoto; Gerald J Harris
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

Review 7.  Ocular myositis.

Authors:  Clare L Fraser; Simon E Skalicky; Avinash Gurbaxani; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

8.  Recurrent orbital myositis mimicking sixth nerve palsy: diagnosis with MR imaging.

Authors:  M Fischer; U Kempkes; P Haage; S Isenmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-24       Impact factor: 3.825

9.  Bilateral orbital tumour as the presentation of mammographically occult breast cancer.

Authors:  M Lell; R Schulz-Wendtland; A Hafner; A Magener; W A Bautz; B F Tomandl
Journal:  Neuroradiology       Date:  2004-07-08       Impact factor: 2.804

Review 10.  Orbital myositis: diagnosis and management.

Authors:  Roberta M S Costa; Oana M Dumitrascu; Lynn K Gordon
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.